≡ Risteys
R9

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm (controls excluding all cancers)

PheWeb

C3_CANCER_EXALLC

No definition available.

Endpoint definition

↥
FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

KELA reimbursements: KELA codes 115|116|130

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

77325

diagram downward connector
C3_CANCER_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 1
First used in FinnGen datafreeze DF9

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 77325 37053 40272
Unadjusted prevalence (%) 20.51 17.58 24.22
Mean age at first event (years) 62.95 59.50 66.12

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.36 [4.02, 4.73] <1e-100 18863
15 years 0.01 1.92 [1.76, 2.09] 2.4e-51 5370
5 years 0.01 5.69 [5.31, 6.10] <1e-100 5692
1 year 0.00 29.13 [26.27, 32.31] <1e-100 6276

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_CANCER_EXALLC – Malignant neoplasm (controls excluding all cancers)
GWS hits: 49

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm (controls excluding all cancers)
after Malignant neoplasm (controls excluding all cancers)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.